Bookmark

Add to MyYahoo RSS

Novo Nordisk AS News

News on Novo Nordisk AS (Ticker: NVO) continually updated from thousands of sources around the net.

8 hrs ago | Hispanic Business

Novo Resources Exercises Election to Accelerate Warrant Expiry Date

Notice of the acceleration of the expiry of the Warrants is being mailed to registered holders of the Warrants.

Comment?

Related Topix: Biotech

Mon Jul 21, 2014

InformationWeek

How E-Discovery Cuts Legal Costs For Novo Nordisk

Pharma giant boosts efficiency, reduces outsourcing labor with in-house technology that discovers and produces electronic information for legal purposes.

Comment?

Related Topix: Biotech, Outsourcing

Thu Jul 17, 2014

Hispanic Business

Novo Resources Exercises Election to Accelerate Warrant Expiry Date

Notice of the acceleration of the expiry of the Warrants is being mailed to registered holders of the Warrants.

Comment?

Related Topix: Biotech

Wed Jul 16, 2014

Seeking Alpha

AntriaBio Presents Vast Upside With Disruptive Once-Weekly Insulin

AntriaBio's once-weekly insulin injection is in early-stage development, but as the examples used have shown, potentially disruptive drugs candidates have warranted rich valuations even at early stages.

Comment?

Related Topix: Biotech, MannKind, Food and Drug Administration, Marketing

Tue Jul 15, 2014

Hispanic Business

Altor Fund III to divest micro acoustic supplier Sonion A/S to...

The acquisition enables Sonion to further focus on maturing new technologies, which will help customers, develop even better hearing devices.

Comment?

Related Topix: Biotech, Headphones

Reuters

Denmark's Novo A/S enters hearing technology sector with Sonion purchase

Danish investment company Novo A/S said it bought hearing technology firm Sonion from Swedish private equity firm Altor, entering a market in which Denmark has been a major player for decades.

Comment?

Related Topix: Biotech, Audiology, Medicine, Headphones

Mon Jul 14, 2014

GlobeNewswire

CORRECTION: Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme

This is a correction of the announcement from 14:33 14.07.2014 CEST. Reason for the correction: Correct attachment Bagsvaerd, Denmark, 14 July 2014 - On 1 May 2014, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the ... (more)

Comment?

Related Topix: Biotech

Thu Jul 10, 2014

BioSpace

Sandoz, Inc. Stays In New Jersey, Moves To Former Home Of Novo Nordisk A/S

The former home of Novo Nordisk, a Danish pharmaceutical company that has sat vacant along Route 1 for more than a year, will soon have a new tenant and new job opportunities.

Comment?

Related Topix: Biotech

Tue Jul 08, 2014

WNEP-TV Moosic

IndyCar Driver Charlie Kimball Races with Diabetes

IndyCar driver Charlie Kimball has something that affects many people in our area.

Comment?

Related Topix: Diabetes, Health, Biotech, Swiftwater, PA, Monroe County, PA

Mon Jul 07, 2014

Investor's Business Daily

Jazz, Novo Among Medicals Showing Healthy Action

Drugmakers and clinical research providers that aim to boost people's well-being worldwide are displaying healthy stock price performance themselves.

Comment?

Related Topix: Biotech, Financial Markets

Freshnews

FDA Approves NovoSevenA RT for the Treatment of Glanzmann's...

Novo Nordisk today announced the US Food and Drug Administration has approved NovoSeven RT as the first recombinant treatment for bleeding episodes and perioperative management in patients with Glanzmann's Thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.

Comment?

Related Topix: Food and Drug Administration, Biotech, Genetics, Medicine

GlobeNewswire

Novo Nordisk A/S: Share repurchase programme

On 1 May 2014, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Comment?

Related Topix: Biotech

Sat Jul 05, 2014

The Jersey Journal

Sandoz Inc. pharmaceuticals stays in N.J., moves to vacant Rt. 1 space in Plainsboro

Sandoz Inc., a major pharmaceutical company that manufactures and markets generic prescription drugs, will be relocating its U.S. headquarters to the 154,000-square-foot space at 100 College Road West in Plainsboro.

Comment?

Related Topix: Plainsboro, NJ, Biotech, Home Listing, Home

Tue Jul 01, 2014

BioSpace

Status Regarding Novo Nordisk A/S's Holding Of Its Own Shares

In continuation of the company's announcements dated 30 January 2014 and 1 May 2014 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S and its wholly-owned affiliates on 30 June 2014 owned 28,223,014 of its own B shares of DKK ... (more)

Comment?

Related Topix: Biotech

BioSpace

Novo Nordisk A/S - Share Repurchase Programme

On 1 May 2014, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Comment?

Related Topix: Biotech

Mon Jun 30, 2014

Investor's Business Daily

Biogen Hemophilia Drugs Launch Into The Unknown

With the launch of Alprolix in May and Eloctate coming in July, Biogen Idec is on the leading edge of the first new class of hemophilia treatments to come along in 15 years.

Comment?

Related Topix: Hemophilia, Health, Biotech, Biogen Idec, Genetics, Medicine

Thu Jun 26, 2014

Investor's Business Daily

Novo, Other Medicals Display Healthy Action

Leaders in buy range could get tougher to find as the market uptrend continues and stocks break out to new highs .

Comment?

Related Topix: Biotech

Seeking Alpha

Novo Nordisk's Diabetes Pill Shows Promise

Novo Nordisk, in partnership with Emisphere and Merrion, is developing an oral GLP-1 analogue pill for the treatment of Type-2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Diabetes, Health, Emisphere Technologies, Healthcare Industry, Insulin (generic), Humulin, Novolin

Wed Jun 25, 2014

Freshnews

Novo Nordisk and NBA Legend Dominique Wilkins Spotlight Full-Court...

Novo Nordisk is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team , a national initiative to help adults with type 2 diabetes customize a full-court approach to managing the everyday challenges of the disease.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Life, Food, Nutrition, Marketing, Pancreatitis, Thyroid Cancer

Reuters

Novo Nordisk to double revenue within a decade: deputy CEO

Danish drugmaker Novo Nordisk, the world's biggest insulin maker, expects to more than double its annual revenue within a decade, its deputy chief executive Kaare Schultz told Reuters.

Comment?

Related Topix: Biotech, Insulin (generic), Humulin, Novolin, Medicine

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••